in our free newsletter.

Thousands benefit from our email every week.


Telecommunications giant AT&T (NYSE:T) is on this list because the need for broadband and wireless data is rock-solid. The company has significant market share in America, which gives it clear economies of scale. And given its investments in 5G and fiber optics, the company stands to benefit from the Biden Administration’s new $42 billion plan to make internet access universal in every U.S. state and territory by 2030 under the Broadband Equity Access and Deployment Program.

AT&T expects to generate over $16 billion in free cash flow this year, which would help underwrite the firm’s hefty 7.4% dividend yield, which is far higher than that of most blue chip stocks at the moment.

More: How much is needed to live off dividends?

Contemporary art has outperformed the S&P 500 by 131% for the past 26 years. Join the exclusive platform to invest in million-dollar works by artists like Banksy, Basquiat, and more. Get started today and diversify your portfolio with art.

Learn More


North America’s energy infrastructure is another timeless asset. Canadian firm Enbridge (NYSE:ENB) operates the largest network of oil and natural gas pipelines across the continent. In recent months the company has announced plans to expand its network as demand for energy rebounds and North American energy producers ramp up exports to Europe.

The fact that Enrbidge derives its value from hard assets and infrastructure makes it a more reliable stock than energy producers and refiners. Enbridge has ramped up its dividend every year for 28 consecutive years.

The stock currently trades at a price-to-earnings ratio of 42 with a 7.2% dividend yield.


Pharmaceutical giant Pfizer (NYSE:PFE) saw sales jump as the world tackled the COVID-19 pandemic. But pandemic sales are now receding and investors have retreated from Pfizer’s stock, which is down around 30% year to date.

Meanwhile, the firm’s revenue was down 29% year over year in the first quarter of 2023.

But the underlying business is still robust. Pfizer has a vast portfolio of lucrative drugs and many more in the pipeline. The stock may be undervalued at the moment, trading at just seven times earnings and the dividend yield is 4.4%.

Investors seeking a contrarian bet should consider adding Pfizer to their watch list.

Meet Your Retirement Goals Effortlessly

The road to retirement may seem long, but with WiserAdvisor, you can find a trusted partner to guide you every step of the way

WiserAdvisor matches you with vetted financial advisors that offer personalized advice to help you to make the right choices, invest wisely, and secure the retirement you've always dreamed of. Start planning early, and get your retirement mapped out today.

About the Author

Vishesh Raisinghani

Vishesh Raisinghani

Freelance Writer

Vishesh Raisinghani is a freelance contributor at MoneyWise. He has been writing about financial markets and economics since 2014 - having covered family offices, private equity, real estate, cryptocurrencies, and tech stocks over that period. His work has appeared in Seeking Alpha, Motley Fool Canada, Motley Fool UK, Mergers & Acquisitions, National Post, Financial Post, and Yahoo Canada.

What to Read Next


The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.